Manuscript Published On Multiorgan Failure Patients Treated With Seastar Medical'S Selective Cytopheretic Device Who Achieved Transplant Eligibility

SCD's ability to improve clinical status of four critically ill pediatric and adult patients across multiple clinical conditions published in Transpl

Related Keywords

Denver ,Colorado ,United States ,Jody Cain ,Eric Schrolff ,Drug Administration ,Linkedin ,Seastar Medical Holding Corporation Nasdaq ,Clinical Development ,Star Medical Holding Corporation ,Selective Cytopheretic Device ,Transplantation Direct ,Transplant Through ,Case Reports Across Multiple Clinical Conditions ,Seastar Medical Vice President ,Medical Affairs ,Seastar Medical ,Device Designation ,Star Medical ,Private Securities Litigation Reform Act ,Annual Report ,